NCT00002506 - Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | Biotech Hunter

Timeline

Start Date

August 31, 1992

Primary Completion Date

January 31, 1996

Study Completion Date

February 28, 1999

Conditions

Cervical CancerEsophageal CancerHead and Neck CancerLung CancerNon-melanomatous Skin CancerPenile Cancer

Interventions

BIOLOGICAL

recombinant interferon alfa

DRUG

isotretinoin

Trial Locations (6)

Baptist Regional Cancer Center - Knoxville, Knoxville

St. Vincent Hospital and Health Care Center, Indianapolis

Bloomington Hospital, Bloomington

Bergan Mercy Medical Center, Omaha

St. Joseph Regional Cancer Center, Bryan

Hoag Memorial Hospital Presbyterian, Newport Beach